Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| PFE | Pfizer Inc. | 1.14% | 33.84 | 0.9% | $1138.25m | |
| JNJ | Johnson & Johnson | 0.01% | 142.50 | 0.7% | $1016.34m | |
| BMY | Bristol-Myers Squibb Co. | -1.17% | 57.43 | 1.0% | $922.01m | |
| MRK | Merck & Co., Inc. | 0.05% | 76.73 | 0.7% | $787.68m | |
| ABBV | AbbVie, Inc. | -1.18% | 96.78 | 1.9% | $725.30m | |
| LLY | Eli Lilly & Co. | -1.84% | 163.39 | 1.1% | $641.93m | |
| AZN | AstraZeneca Plc | -0.40% | 53.76 | 1.2% | $288.49m | |
| RPRX | Royalty Pharma Plc | -1.49% | 47.64 | 0.1% | $203.76m | |
| NVS | Novartis AG | -0.36% | 87.03 | 0.2% | $143.34m | |
| RGEN | Repligen Corp. | -1.97% | 126.13 | 7.1% | $115.34m | |
| GSK | GlaxoSmithKline Plc | -1.14% | 39.91 | 0.2% | $109.88m | |
| NVO | Novo Nordisk A/S | -0.26% | 65.44 | 0.1% | $88.47m | |
| RETA | Reata Pharmaceuticals, Inc. | -1.10% | 154.40 | 3.4% | $79.42m | |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | -2.31% | 74.14 | 0.0% | $67.56m | |
| SNY | Sanofi | -0.53% | 50.28 | 0.2% | $63.74m |
Company Profile
Hoth Therapeutics, Inc. is a development stage biopharmaceutical company, which engages in the provision and development of therapeutic platform. The company focuses on the patients suffering from conditions such as atopic dermatitis, also known as eczema. It offers BioLexa Platform, a proprietary, patented, drug compound platform for the treatment of eczema. The company was founded by Robbie Knie, Matthew D. Eitner, and James Ahern in May 2017 and is headquartered in New York, NY.